| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.446 | 0.004 | 0.446 | Neuronal nicotinic receptor antagonist | 0.363 0.004 CID_135508231 0.302 0.005 CID_135524501 | ||
| 0.409 | 0.005 | 0.409 | Acetylcholine nicotinic antagonist | 0.339 0.005 CID_135508231 0.287 0.007 CID_135524501 | ||
| 0.465 | 0.069 | 0.465 | MAP kinase 1 inhibitor | 0.416 0.097 CID_135508231 0.416 0.096 CID_135524501 | ||
| 0.379 | 0.003 | 0.379 | Acetylcholine nicotinic agonist | 0.301 0.004 CID_135508231 0.274 0.004 CID_135524501 | ||
| 0.383 | 0.011 | 0.383 | Cholinergic | 0.317 0.017 CID_135508231 0.324 0.016 CID_135524501 | ||
| 0.345 | 0.011 | 0.345 | Tumour necrosis factor antagonist | 0.294 0.019 CID_135508231 0.291 0.02 CID_135524501 | ||
| 0.321 | 0.003 | 0.321 | Nicotinic neuronal receptor agonist | 0.19 0.004 CID_135508231 0.169 0.005 CID_135524501 | ||
| 0.359 | 0.051 | 0.359 | Nootropic | 0.28 0.085 CID_135508231 0.259 0.1 CID_135524501 | ||
| 0.425 | 0.124 | 0.483 | Antiinflammatory | 0.479 0.097 CID_135508231 0.483 0.095 CID_135524501 | CID_135524501 | |
| 0.328 | 0.032 | 0.34 | Cyclic AMP phosphodiesterase inhibitor | 0.34 0.028 CID_135508231 0.335 0.029 CID_135524501 | CID_135508231 | |
| 0.293 | 0.003 | 0.293 | Nicotinic alpha7 receptor agonist | 0.167 0.004 CID_135508231 0.155 0.004 CID_135524501 | ||
| 0.396 | 0.116 | 0.449 | Apoptosis agonist | 0.44 0.096 CID_135508231 0.449 0.092 CID_135524501 | CID_135524501 | |
| 0.34 | 0.081 | 0.356 | Thioredoxin glutathione reductase inhibitor | 0.322 0.089 CID_135508231 0.356 0.074 CID_135524501 | CID_135524501 | |
| 0.29 | 0.041 | 0.296 | Sigma receptor agonist | 0.296 0.04 CID_135508231 0.266 0.045 CID_135524501 | CID_135508231 | |
| 0.24 | 0.009 | 0.24 | Acetylcholine agonist | 0.166 0.021 CID_135508231 0.159 0.023 CID_135524501 | ||
| 0.269 | 0.044 | 0.269 | Platelet aggregation inhibitor | 0.215 0.071 CID_135508231 0.21 0.074 CID_135524501 | ||
| 0.276 | 0.057 | 0.314 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | 0.314 0.046 CID_135508231 0.309 0.048 CID_135524501 | CID_135508231 | |
| 0.302 | 0.09 | 0.302 | Calcium channel activator | 0.288 0.104 CID_135508231 0.297 0.095 CID_135524501 | ||
| 0.271 | 0.063 | 0.301 | Dyrk kinase inhibitor | 0.301 0.052 CID_135508231 0.296 0.054 CID_135524501 | CID_135508231 | |
| 0.183 | 0.005 | 0.183 | Nicotinic alpha4beta2 receptor antagonist | 0.147 0.008 CID_135508231 0.145 0.009 CID_135524501 | ||
| 0.201 | 0.026 | 0.201 | Platelet activating factor antagonist | 0.139 0.051 CID_135508231 0.134 0.054 CID_135524501 | ||
| 0.177 | 0.005 | 0.177 | Nicotinic receptor alpha7 subunit antagonist | 0.133 0.008 CID_135508231 0.115 0.01 CID_135524501 | ||
| 0.24 | 0.079 | 0.24 | Tumour necrosis factor alpha release inhibitor | 0.232 0.084 CID_135508231 0.24 0.079 CID_135524501 | ||
| 0.197 | 0.037 | 0.197 | Toll-Like receptor 9 antagonist | 0.154 0.061 CID_135508231 0.136 0.072 CID_135524501 | ||
| 0.272 | 0.112 | 0.37 | Transcription factor NF kappa B inhibitor | 0.37 0.071 CID_135508231 0.358 0.074 CID_135524501 | CID_135508231 | |
| 0.167 | 0.027 | 0.167 | Polo-like kinase-4 inhibitor | 0.149 0.036 CID_135508231 0.152 0.034 CID_135524501 | ||
| 0.316 | 0.177 | 0.348 | Caspase 9 stimulant | 0.348 0.147 CID_135508231 0.319 0.174 CID_135524501 | CID_135508231 | |
| 0.197 | 0.059 | 0.221 | Amyloid beta precursor protein antagonist | 0.21 0.051 CID_135508231 0.221 0.045 CID_135524501 | CID_135524501 | |
| 0.148 | 0.017 | 0.148 | CYP2A6 inhibitor | 0.118 0.028 CID_135508231 0.098 0.037 CID_135524501 | ||
| 0.147 | 0.025 | 0.147 | Breast cancer-resistant protein inhibitor | 0.144 0.026 CID_135508231 0.139 0.028 CID_135524501 | ||
| 0.17 | 0.049 | 0.179 | Tubulin antagonist | 0.168 0.05 CID_135508231 0.179 0.045 CID_135524501 | CID_135524501 | |
| 0.197 | 0.094 | 0.211 | Nitric-oxide synthase stimulant | 0.211 0.072 CID_135508231 0.188 0.111 CID_135524501 | CID_135508231 | |
| 0.21 | 0.107 | 0.29 | Superoxide dismutase inhibitor | 0.249 0.075 CID_135508231 0.29 0.054 CID_135524501 | CID_135524501 | |
| 0.133 | 0.032 | 0.168 | HIV-1 integrase (Overall Integration) inhibitor | 0.146 0.027 CID_135508231 0.168 0.019 CID_135524501 | CID_135524501 | |
| 0.272 | 0.172 | 0.279 | Transcription factor inhibitor | 0.245 0.19 CID_135508231 0.279 0.167 CID_135524501 | CID_135524501 | |
| 0.151 | 0.054 | 0.151 | Acetylcholinesterase inhibitor | 0.133 0.067 CID_135508231 0.139 0.063 CID_135524501 | ||
| 0.147 | 0.051 | 0.151 | Acetylcholine antagonist | 0.151 0.049 CID_135508231 0.141 0.055 CID_135524501 | CID_135508231 | |
| 0.148 | 0.053 | 0.152 | Cholinergic antagonist | 0.152 0.051 CID_135508231 0.141 0.058 CID_135524501 | CID_135508231 | |
| 0.166 | 0.076 | 0.22 | Mcl-1 antagonist | 0.196 0.058 CID_135508231 0.22 0.046 CID_135524501 | CID_135524501 | |
| 0.14 | 0.058 | 0.14 | Death-associated protein kinase 1 inhibitor | 0.131 0.078 CID_135508231 0.13 0.08 CID_135524501 | ||
| 0.265 | 0.183 | 0.273 | DNA polymerase beta inhibitor | 0.257 0.188 CID_135508231 0.273 0.179 CID_135524501 | CID_135524501 | |
| 0.142 | 0.064 | 0.179 | MAO inhibitor | 0.149 0.061 CID_135508231 0.179 0.048 CID_135524501 | CID_135524501 | |
| 0.237 | 0.165 | 0.31 | Histamine release inhibitor | 0.31 0.118 CID_135508231 0.257 0.15 CID_135524501 | CID_135508231 | |
| 0.15 | 0.082 | 0.189 | Melanin inhibitor | 0.189 0.046 CID_135508231 0.182 0.05 CID_135524501 | CID_135508231 | |
| 0.117 | 0.052 | 0.117 | Acetylcholine release stimulant | |||
| 0.092 | 0.033 | 0.107 | Histone deacetylase stimulant | 0.107 0.024 CID_135508231 0.103 0.026 CID_135524501 | CID_135508231 | |
| 0.092 | 0.033 | 0.107 | Histone deacetylase SIRT1 stimulant | 0.107 0.024 CID_135508231 0.103 0.026 CID_135524501 | CID_135508231 | |
| 0.109 | 0.054 | 0.109 | Gastric antisecretory | 0.091 0.077 CID_135508231 | ||
| 0.213 | 0.162 | 0.237 | Antithrombotic | 0.237 0.137 CID_135508231 0.208 0.168 CID_135524501 | CID_135508231 | |
| 0.21 | 0.159 | 0.21 | Angiogenesis inhibitor | 0.197 0.173 CID_135508231 0.201 0.168 CID_135524501 | ||
| 0.09 | 0.041 | 0.091 | Thioredoxin reductase inhibitor | 0.091 0.039 CID_135508231 0.091 0.04 CID_135524501 | CID_135524501 | |
| 0.16 | 0.112 | 0.16 | Antimitotic | 0.158 0.114 CID_135508231 0.153 0.119 CID_135524501 | ||
| 0.077 | 0.029 | 0.098 | Aromatase inhibitor | 0.088 0.024 CID_135508231 0.098 0.022 CID_135524501 | CID_135524501 | |
| 0.135 | 0.088 | 0.148 | Dual specificity tyrosine-phosphorylation regulated kinase 1B inhibitor | 0.148 0.075 CID_135508231 0.14 0.083 CID_135524501 | CID_135508231 | |
| 0.158 | 0.111 | 0.161 | Death-associated protein kinase 3 inhibitor | 0.158 0.11 CID_135508231 0.161 0.106 CID_135524501 | CID_135524501 | |
| 0.106 | 0.06 | 0.132 | MAO A inhibitor | 0.121 0.052 CID_135508231 0.132 0.047 CID_135524501 | CID_135524501 | |
| 0.077 | 0.031 | 0.102 | Beta tubulin antagonist | 0.09 0.025 CID_135508231 0.102 0.021 CID_135524501 | CID_135524501 | |
| 0.095 | 0.049 | 0.095 | Phosphodiesterase IV inhibitor | |||
| 0.064 | 0.02 | 0.064 | Nicotinic receptor alpha4 subunit antagonist | 0.054 0.027 CID_135508231 0.052 0.029 CID_135524501 | ||
| 0.107 | 0.064 | 0.107 | CDC-like kinase 3 inhibitor | 0.102 0.075 CID_135508231 0.102 0.074 CID_135524501 | ||
| 0.109 | 0.066 | 0.109 | Interleukin 2 antagonist | 0.102 0.084 CID_135508231 | ||
| 0.109 | 0.071 | 0.109 | Interleukin 1b antagonist | |||
| 0.074 | 0.036 | 0.074 | Glutamate (mGluR7) antagonist | 0.066 0.051 CID_135508231 | ||
| 0.125 | 0.09 | 0.129 | CDC-like kinase 1 inhibitor | 0.118 0.097 CID_135508231 0.129 0.086 CID_135524501 | CID_135524501 | |
| 0.098 | 0.064 | 0.098 | Butyrylcholinesterase inhibitor | 0.082 0.081 CID_135524501 | ||
| 0.23 | 0.199 | 0.339 | Alpha-glucosidase inhibitor | 0.333 0.144 CID_135508231 0.339 0.141 CID_135524501 | CID_135524501 | |
| 0.059 | 0.032 | 0.077 | Alpha tubulin antagonist | 0.071 0.023 CID_135508231 0.077 0.021 CID_135524501 | CID_135524501 | |
| 0.065 | 0.039 | 0.106 | HIV-1 integrase (Strand Transfer) inhibitor | 0.099 0.023 CID_135508231 0.106 0.02 CID_135524501 | CID_135524501 | |
| 0.106 | 0.08 | 0.156 | Topoisomerase II inhibitor | 0.156 0.047 CID_135508231 0.145 0.052 CID_135524501 | CID_135508231 | |
| 0.062 | 0.039 | 0.062 | Alpha 2 adrenoreceptor agonist | 0.062 0.04 CID_135508231 | ||
| 0.158 | 0.135 | 0.268 | Free radical scavenger | 0.266 0.062 CID_135508231 0.268 0.061 CID_135524501 | CID_135524501 | |
| 0.082 | 0.061 | 0.091 | Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor | 0.091 0.048 CID_135508231 0.091 0.047 CID_135524501 | CID_135524501 | |
| 0.114 | 0.094 | 0.114 | Toll-Like receptor antagonist | 0.112 0.098 CID_135508231 | ||
| 0.035 | 0.015 | 0.035 | Nicotinic alpha3beta4 receptor agonist | 0.029 0.023 CID_135508231 | ||
| 0.061 | 0.042 | 0.061 | Cyclin D1 inhibitor | 0.054 0.053 CID_135524501 | ||
| 0.063 | 0.044 | 0.112 | HIV-1 integrase (3'-Processing) inhibitor | 0.101 0.025 CID_135508231 0.112 0.022 CID_135524501 | CID_135524501 | |
| 0.141 | 0.123 | 0.141 | Clk dual-specificity kinase inhibitor | |||
| 0.128 | 0.111 | 0.128 | MAP kinase 3 inhibitor | 0.125 0.122 CID_135524501 | ||
| 0.13 | 0.118 | 0.166 | Nitric oxide antagonist | 0.165 0.084 CID_135508231 0.166 0.084 CID_135524501 | CID_135524501 | |
| 0.052 | 0.04 | 0.052 | Nicotinic alpha3beta2 receptor antagonist | |||
| 0.034 | 0.023 | 0.037 | Tubulin agonist | 0.037 0.018 CID_135508231 0.037 0.018 CID_135524501 | CID_135524501 | |
| 0.177 | 0.167 | 0.271 | Lipoxygenase inhibitor | 0.246 0.103 CID_135508231 0.271 0.086 CID_135524501 | CID_135524501 | |
| 0.065 | 0.058 | 0.065 | Polo-like kinase-2 inhibitor | |||
| 0.106 | 0.099 | 0.137 | Bone formation stimulant | 0.137 0.07 CID_135508231 0.131 0.075 CID_135524501 | CID_135508231 | |
| 0.085 | 0.081 | 0.085 | Toll-Like receptor 3 antagonist | |||
| 0.08 | 0.076 | 0.102 | MAO B inhibitor | 0.08 0.075 CID_135508231 0.102 0.059 CID_135524501 | CID_135524501 | |
| 0.123 | 0.12 | 0.123 | Polo-like kinase-3 inhibitor | |||
| 0.097 | 0.094 | 0.097 | Beta amyloid protein antagonist | |||
| 0.067 | 0.064 | 0.067 | Orexin receptor 1 antagonist | |||
| 0.131 | 0.128 | 0.168 | DNA methyltransferase I inhibitor | 0.168 0.088 CID_135508231 0.159 0.095 CID_135524501 | CID_135508231 | |
| 0.017 | 0.015 | 0.017 | Alpha 2c adrenoreceptor agonist | |||
| 0.082 | 0.08 | 0.082 | Polo-like kinase-1 inhibitor | |||
| 0.106 | 0.104 | 0.133 | NADPH oxidase inhibitor | 0.133 0.068 CID_135508231 0.13 0.072 CID_135524501 | CID_135508231 | |
| 0.058 | 0.057 | 0.058 | Aryl hydrocarbon receptor antagonist | |||
| 0.108 | 0.112 | 0.119 | Dual specificity tyrosine-phosphorylation-regulated kinase 4 inhibitor | 0.119 0.102 CID_135524501 | CID_135524501 | |
| 0.13 | 0.138 | 0.17 | DNA methylase inhibitor | 0.17 0.101 CID_135508231 0.162 0.107 CID_135524501 | CID_135508231 | |
| 0.044 | 0.053 | 0.074 | Xanthine dehydrogenase inhibitor | 0.074 0.028 CID_135508231 0.072 0.029 CID_135524501 | CID_135508231 | |
| 0.055 | 0.07 | 0.068 | Sirtuin 1 inhibitor | 0.062 0.055 CID_135508231 0.068 0.047 CID_135524501 | CID_135524501 | |
| 0.091 | 0.106 | 0.099 | TRPA1 agonist | 0.099 0.09 CID_135508231 0.098 0.092 CID_135524501 | CID_135508231 | |
| 0.183 | 0.199 | 0.224 | Caspase 3 stimulant | 0.22 0.143 CID_135508231 0.224 0.138 CID_135524501 | CID_135524501 | |
| 0.022 | 0.042 | 0.03 | Estrogen-related receptor alpha antagonist | 0.03 0.026 CID_135508231 | CID_135508231 | |
| 0.151 | 0.176 | 0.162 | ErbB-1 antagonist | 0.162 0.149 CID_135508231 | CID_135508231 | |
| 0.149 | 0.175 | 0.164 | DNA damaging | 0.163 0.154 CID_135508231 0.164 0.153 CID_135524501 | CID_135524501 | |
| 0.196 | 0.231 | 0.223 | DNA directed DNA polymerase inhibitor | 0.223 0.21 CID_135524501 | CID_135524501 | |
| 0.106 | 0.141 | 0.136 | Farnesoid X receptor antagonist | 0.136 0.072 CID_135508231 0.129 0.085 CID_135524501 | CID_135508231 | |
| 0.131 | 0.167 | 0.172 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.172 0.119 CID_135524501 | CID_135524501 | |
| 0.116 | 0.153 | 0.187 | Pyruvate kinase inhibitor | 0.16 0.107 CID_135508231 0.187 0.089 CID_135524501 | CID_135524501 | |
| 0.134 | 0.175 | 0.15 | Histone acetyltransferase inhibitor | 0.15 0.14 CID_135524501 | CID_135524501 | |
| 0.185 | 0.229 | 0.209 | GABA C receptor rho-3 antagonist | 0.209 0.196 CID_135508231 | CID_135508231 | |
| 0.061 | 0.114 | 0.099 | Bronchodilator | 0.085 0.08 CID_135508231 0.099 0.065 CID_135524501 | CID_135524501 | |
| 0.121 | 0.18 | 0.131 | Heat shock protein 70 antagonist | 0.131 0.117 CID_135508231 0.129 0.126 CID_135524501 | CID_135508231 | |
| 0.049 | 0.113 | 0.074 | HIV-1 integrase inhibitor | 0.072 0.046 CID_135508231 0.074 0.044 CID_135524501 | CID_135524501 | |
| 0.053 | 0.118 | 0.071 | Keratolytic | 0.071 0.063 CID_135508231 0.069 0.067 CID_135524501 | CID_135508231 | |
| 0.122 | 0.189 | 0.147 | Neurotensin receptor agonist | 0.147 0.109 CID_135508231 | CID_135508231 | |
| 0.049 | 0.128 | 0.111 | Monophenol monooxygenase inhibitor | 0.111 0.067 CID_135508231 0.109 0.069 CID_135524501 | CID_135508231 | |
| 0.065 | 0.145 | 0.086 | Xanthine oxidase inhibitor | 0.086 0.078 CID_135508231 | CID_135508231 | |
| 0.067 | 0.149 | 0.12 | Amylase inhibitor | 0.118 0.082 CID_135508231 0.12 0.081 CID_135524501 | CID_135524501 | |
| 0.112 | 0.199 | 0.166 | Antiamyloidogenic | 0.156 0.139 CID_135508231 0.166 0.127 CID_135524501 | CID_135524501 | |
| 0.088 | 0.177 | 0.181 | Amyloid beta aggregation inhibitor | 0.156 0.104 CID_135508231 0.181 0.088 CID_135524501 | CID_135524501 | |
| 0.118 | 0.213 | 0.224 | Antioxidant | 0.222 0.1 CID_135508231 0.224 0.099 CID_135524501 | CID_135524501 | |
| 0.094 | 0.193 | 0.124 | Papain-like protease (SARS coronavirus) inhibitor | 0.117 0.089 CID_135508231 0.124 0.073 CID_135524501 | CID_135524501 | |
| 0.158 | 0.261 | 0.267 | 15-Lipoxygenase inhibitor | 0.246 0.167 CID_135508231 0.267 0.152 CID_135524501 | CID_135524501 | |
| 0.117 | 0.22 | 0.204 | Streptokinase A inhibitor | 0.204 0.13 CID_135524501 | CID_135524501 | |
| 0.053 | 0.174 | 0.103 | Cystathionine beta-synthase inhibitor | 0.091 0.088 CID_135508231 0.103 0.073 CID_135524501 | CID_135524501 | |
| 0.094 | 0.216 | 0.132 | Interleukin 6 antagonist | 0.132 0.122 CID_135524501 | CID_135524501 | |
| 0.102 | 0.233 | 0.128 | MAP kinase kinase 4 inhibitor | 0.128 0.121 CID_135508231 | CID_135508231 | |
| 0.079 | 0.232 | 0.135 | Heat shock protein 90 alpha antagonist | 0.135 0.105 CID_135524501 | CID_135524501 | |
| 0.066 | 0.223 | 0.124 | Peroxidase inhibitor | 0.124 0.096 CID_135508231 | CID_135508231 | |
| 0.065 | 0.223 | 0.12 | Interleukin 4 antagonist | 0.12 0.086 CID_135508231 0.117 0.09 CID_135524501 | CID_135508231 | |
| 0.102 | 0.262 | 0.12 | CC chemokine 6 receptor antagonist | 0.12 0.119 CID_135524501 | CID_135524501 | |
| 0.073 | 0.238 | 0.131 | Heat shock protein 90 antagonist | 0.131 0.096 CID_135524501 | CID_135524501 | |
| 0.044 | 0.257 | 0.112 | Lipid peroxidase inhibitor | 0.112 0.102 CID_135524501 | CID_135524501 | |
| 0.038 | 0.288 | 0.105 | Estrogen receptor beta antagonist | 0.105 0.056 CID_135508231 0.095 0.075 CID_135524501 | CID_135508231 | |
| 0.041 | 0.352 | 0.111 | Estrogen antagonist | 0.111 0.073 CID_135508231 0.1 0.099 CID_135524501 | CID_135508231 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |